ABOUT FRANEK: Mission | Management | Corporate Overview | Location | Business Partners | Employment

FTI specializes in providing Laboratory Productivity/Protection Systems (LPS) for medical, analytical, diagnostics, pharmaceutical and biotechnology instrumentation systems applications. The key scientific and medical LPS applications are in:

• Drug discovery
• Oncology
• DNA-PCR, Genomics and Proteomics research
• Pharmaceutical production
• Clinical chemistry
• Immunology & cytometry
• Diagnostic imaging
• Hematology and blood banking
• FDA 510(k) patient contact applications
• Forensics
• Scientific / Biotechnology commercial research & production

FTI provides an energy technology bridge between the energy production and distribution sector (utility and associated distribution network) and the end user analytical laboratory (GxP) operator. The application of FTI's certified purpose built and application specific power systems (Category III LPS/UPS) provide assurance that the instrumentation system(s) and the resulting data analysis/reports continuously meet the performance standards originally established for the instrumentation.

Power quality problems represent a large cost to the healthcare and scientific research industry in terms of lost productivity, expensive re-testing and re-calibration, as well as lost reporting time. Data integrity is suspect during episodes of inconsistent energy availability, which is so prevalent in the United States today. FTI's primary goals are to protect the integrity of the analytical results, laboratory or surgical productivity and to safeguard against undesired transient power that can cause equipment damage to sensitive instrumentation. Additionally, by providing a reliable energy source, instrumentation system power integrity and availability is achieved.

FTI has over 20 years of laboratory and medical instrumentation systems applications and several Billions in protected instrumentation and system assets. FTI is uniquely qualified to provide solutions to organizations desiring to meet the electronic reporting requirements of the FDA’s 21 CFR Part 11, as well as meeting the current needs of bioterrorism technology preparedness. FTI may be viewed at: www.21CFRPart11.com/pages/sol_prov/analyt_instr_softwr.htm.

Franek Technologies is a Working Group member of AdvaMed’s Medical Technology Preparedness Council and is a FDA 21 CFR Part 11 solution provider